SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U404. A total of 1 filers reported holding SIERRA ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $409,000 | – | 7,447 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 54,654 | $1,752,000 | 88.13% |
| Vivo Capital, LLC | 3,329,511 | $106,711,000 | 7.35% |
| Paradigm Biocapital Advisors LP | 771,314 | $24,721,000 | 6.54% |
| Frazier Life Sciences Management, L.P. | 2,342,198 | $75,067,000 | 6.40% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 443,381 | $14,210,000 | 5.88% |
| Ghost Tree Capital, LLC | 325,000 | $10,416,000 | 2.26% |
| Kynam Capital Management, LP | 193,280 | $6,195,000 | 2.01% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $9,615,000 | 1.92% |
| Parkman Healthcare Partners LLC | 151,915 | $4,869,000 | 1.42% |
| Sofinnova Investments, Inc. | 572,297 | $18,342,000 | 1.39% |